EP1139913A4 - Zusammensetzungen und substanzen sowie deren anwendung als nociceptische, antianxiolytische und anabolische wirkstoffe - Google Patents

Zusammensetzungen und substanzen sowie deren anwendung als nociceptische, antianxiolytische und anabolische wirkstoffe

Info

Publication number: EP1139913A4
Authority: EP; European Patent Office
Prior art keywords: anabolisers; nociceptives; anxiolytics; formulations; composition
Prior art date: 1999-01-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00904212A

Other languages

English (en)

French (fr)

Other versions

EP1139913A1 (de

Inventor

Jonathan W Nyce

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

East Carolina University

Original Assignee

East Carolina University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-05

Filing date

2000-01-05

Publication date

2002-09-11

2000-01-05 Application filed by East Carolina University filed Critical East Carolina University

2001-10-10 Publication of EP1139913A1 publication Critical patent/EP1139913A1/de

2002-09-11 Publication of EP1139913A4 publication Critical patent/EP1139913A4/de

Status Withdrawn legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title 2
239000002249 anxiolytic agent Substances 0.000 title 1
229940005530 anxiolytics Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Virology (AREA)
Anesthesiology (AREA)

EP00904212A 1999-01-05 2000-01-05 Zusammensetzungen und substanzen sowie deren anwendung als nociceptische, antianxiolytische und anabolische wirkstoffe Withdrawn EP1139913A4 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11477399P	1999-01-05	1999-01-05
US114773P		1999-01-05
PCT/US2000/000180 WO2000040172A1 (en)	1999-01-05	2000-01-05	Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents

Publications (2)

Publication Number	Publication Date
EP1139913A1 EP1139913A1 (de)	2001-10-10
EP1139913A4 true EP1139913A4 (de)	2002-09-11

Family

ID=22357344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00904212A Withdrawn EP1139913A4 (de)	1999-01-05	2000-01-05	Zusammensetzungen und substanzen sowie deren anwendung als nociceptische, antianxiolytische und anabolische wirkstoffe

Country Status (9)

Country	Link
EP (1)	EP1139913A4 (de)
JP (1)	JP2003523933A (de)
KR (1)	KR20010089782A (de)
CN (1)	CN1354640A (de)
AU (1)	AU2600000A (de)
BR (1)	BR0007397A (de)
CA (1)	CA2356368A1 (de)
IL (1)	IL143644A0 (de)
WO (1)	WO2000040172A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1102578A4 (de) *	1998-08-03	2005-05-18	Epigenesis Pharmaceuticals Inc	Neuer analgetischer, antiinflammatorischr und wundheilender wirksoff
KR100348888B1 (en) *	2001-12-11	2002-08-14	Chang Eun Jung	Method for relieving violence and spare diet of estrous deer and method for promoting growth of antlers thereof
WO2009051609A1 (en)	2007-10-19	2009-04-23	Pardee Joel D	Metabolic enhancement therapy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0388827A1 (de) *	1989-03-22	1990-09-26	BIORESEARCH S.p.A.	Verwendung von 5-Methyltetrahydrofolsäure, 5-Formyltetrahydrofolsäure sowie deren pharmazeutisch geeigneten Salzen zur Herstellung von Arzneimitteln mit gesteuerter Freigabe und wirksam in der Therapie organisch mentaler Störungen sowie die entsprechenden Arzneimittel
WO1996025935A1 (en) *	1995-02-24	1996-08-29	East Carolina University	Method of treating adenosine depletion
WO1997027764A1 (en) *	1996-01-31	1997-08-07	South Alabama Medical Science Foundation	Food and vitamin preparations containing the natural isomer of reduced folates
WO1998019690A1 (en) *	1996-11-06	1998-05-14	Bristol-Myers Squibb Company	Method for treating alzheimer's disease
WO2000007566A1 (en) *	1998-08-03	2000-02-17	Epigenesis Pharmaceuticals, Inc.	A new analgesic, anti-inflammatory and wound healing agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5767278A (en) *	1995-10-06	1998-06-16	Geron Corporation	Telomerase inhibitors

2000
- 2000-01-05 CA CA002356368A patent/CA2356368A1/en not_active Abandoned
- 2000-01-05 WO PCT/US2000/000180 patent/WO2000040172A1/en not_active Ceased
- 2000-01-05 IL IL14364400A patent/IL143644A0/xx unknown
- 2000-01-05 BR BR0007397-0A patent/BR0007397A/pt not_active IP Right Cessation
- 2000-01-05 EP EP00904212A patent/EP1139913A4/de not_active Withdrawn
- 2000-01-05 AU AU26000/00A patent/AU2600000A/en not_active Abandoned
- 2000-01-05 JP JP2000591931A patent/JP2003523933A/ja not_active Withdrawn
- 2000-01-05 CN CN00802582A patent/CN1354640A/zh active Pending
- 2000-01-05 KR KR1020017008574A patent/KR20010089782A/ko not_active Withdrawn

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0388827A1 (de) *	1989-03-22	1990-09-26	BIORESEARCH S.p.A.	Verwendung von 5-Methyltetrahydrofolsäure, 5-Formyltetrahydrofolsäure sowie deren pharmazeutisch geeigneten Salzen zur Herstellung von Arzneimitteln mit gesteuerter Freigabe und wirksam in der Therapie organisch mentaler Störungen sowie die entsprechenden Arzneimittel
WO1996025935A1 (en) *	1995-02-24	1996-08-29	East Carolina University	Method of treating adenosine depletion
WO1997027764A1 (en) *	1996-01-31	1997-08-07	South Alabama Medical Science Foundation	Food and vitamin preparations containing the natural isomer of reduced folates
WO1998019690A1 (en) *	1996-11-06	1998-05-14	Bristol-Myers Squibb Company	Method for treating alzheimer's disease
WO2000007566A1 (en) *	1998-08-03	2000-02-17	Epigenesis Pharmaceuticals, Inc.	A new analgesic, anti-inflammatory and wound healing agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRENIA MAUREEN L ET AL: "Methanol inhalation toxicity.", ANNALS OF EMERGENCY MEDICINE, vol. 22, no. 12, 1993, pages 1919 - 1923, XP001080384, ISSN: 0196-0644 *
See also references of WO0040172A1 *

Also Published As

Publication number	Publication date
WO2000040172A1 (en)	2000-07-13
EP1139913A1 (de)	2001-10-10
CN1354640A (zh)	2002-06-19
AU2600000A (en)	2000-07-24
JP2003523933A (ja)	2003-08-12
WO2000040172B1 (en)	2000-11-02
IL143644A0 (en)	2002-04-21
KR20010089782A (ko)	2001-10-08
CA2356368A1 (en)	2000-07-13
BR0007397A (pt)	2001-10-30

Legal Events

Date	Code	Title	Description
2001-08-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-10-10	17P	Request for examination filed	Effective date: 20010625
2001-10-10	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-09-11	A4	Supplementary search report drawn up and despatched	Effective date: 20020726
2002-09-11	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-09-11	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/519 A, 7A 61K 31/5685 B, 7A 61K 31/569 B, 7A 61K 45/06 B, 7A 61P 1/08 B, 7A 61P 25/22 B
2003-03-26	17Q	First examination report despatched	Effective date: 20030210
2004-01-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-02-25	18D	Application deemed to be withdrawn	Effective date: 20030821

Publication	Publication Date	Title
MA26771A1 (fr)	2004-12-20	Benzoheterocycles et leur utilisation comme inhibiteurs de mek.
NO20021116D0 (no)	2002-03-06	Ny sammensetning
MA25688A1 (fr)	2003-04-01	2-thio-3, 5-dicyano-4-aryl-6-aminopyridines substituees et leur utilisation.
IS6120A (is)	2001-10-22	Lyfjablanda
ATE277111T1 (de)	2004-10-15	Farbstabile superabsorbierende polymerzusammensetzung
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
ITMI991754A0 (it)	1999-08-04	Composizioni cosmetiche
DE60045324D1 (de)	2011-01-13	Impfstoffzusammensetzung
DE60014105D1 (de)	2004-10-28	Verbesserte herbizidzusammensetzunen
DE60031954D1 (de)	2007-01-04	Lippenstiftzusammensetzung
DE60021018D1 (de)	2005-08-04	Polymerzusammensetzungen
NO20021115L (no)	2002-04-30	Ny sammensetning
ID29785A (id)	2001-10-11	Komposisi-komposisi sampo
DE60010547D1 (de)	2004-06-17	Vernetzbare Fluoropolyetherzusammensetzungen
PT1086701E (pt)	2006-05-31	Composicao laxante contendo simeticone
DE60007731D1 (de)	2004-02-19	Schweisshemmende zusammensetzungen
DE60015460D1 (de)	2004-12-09	Polymerzusammensetzungen
FR2807052B1 (fr)	2003-08-15	Compositions silico-acryliques, leur procede de preparation et leur utilisation
IS6398A (is)	2002-05-27	Lyfjablöndur
DE60018079D1 (de)	2005-03-17	Polymerzusammensetzung
FR2829694B1 (fr)	2003-12-05	Nouvelles compositions cosmetiques comprenant des extraits vegetaux et leur utilisation comme agent antiradicalaire
EP1451183A4 (de)	2006-03-15	Dimere verbindungen und deren verwendung als antivirale mittel
DK199901730A (da)	2000-12-23	Ny Sammensætning
DE60020682D1 (de)	2005-07-14	Resorcinenthaltende zusammensetzung
AR025731A1 (es)	2002-12-11	"ditiepino [6,5-b] piridinas benzo-fusionadas y composiciones y metodos relacionados"